SCHEMBL7576014

SCHEMBL7576014

Cc1ccc(NC(C(=O)O)c2ccccc2)cc1[N+](=O)[O-]

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.60
MAPT P10636 6/20 0.60
MEN1 O00255 6/20 0.60
KMT2A Q03164 6/20 0.60
NPC1 O15118 5/20 0.60
RAB9A P51151 5/20 0.60
LMNA P02545 2/20 0.60
MAPK1 P28482 2/20 0.60
CES2 O00748 1/20 0.50
CES1 P23141 1/20 0.50
HPGD P15428 2/20 0.49
PPIA P62937 1/20 0.48
TSHR P16473 1/20 0.48
ALDH1A1 P00352 3/20 0.47
ATM Q13315 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
GAA P10253 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7578041 0.84 ALDH1A1 (0.60) SMN1; SMN2MAPTMEN1KMT2ANPC1
SCHEMBL7584783 0.84 LMNA (0.60) SMN1; SMN2MAPTMEN1KMT2ALMNA
SCHEMBL7583934 0.82 ALDH1A1 (0.49) SMN1; SMN2MAPTMEN1KMT2ANPC1
SCHEMBL27992082 0.80 ALDH1A1 (0.61) SMN1; SMN2MAPTMEN1KMT2ANPC1
SCHEMBL13949527 0.79 MEN1 (0.67) SMN1; SMN2MAPTMEN1KMT2ANPC1
SCHEMBL5882870 0.78 MAPT (0.44) SMN1; SMN2MAPTMEN1KMT2ANPC1
SCHEMBL7576573 0.78 RAB9A (0.49) SMN1; SMN2MAPTMEN1KMT2ANPC1
SCHEMBL2482554 0.78 RAB9A (0.50) SMN1; SMN2MAPTMEN1KMT2ANPC1
SCHEMBL13240816 0.78 RAB9A (0.50) SMN1; SMN2MAPTMEN1KMT2ANPC1
SCHEMBL7574185 0.77 HPGD (0.57) MAPTMEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242069-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2002-09-25 EP disclosed
WO-2001003684-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2001-01-18 WO disclosed